Latest News
AstraZeneca purchases 360,000 shares for cancellation
18 May 2012 - Anglo-Swedish pharmaceutical company AstraZeneca plc (LSE:AZN) (STO:AZN) (NYSE:AZN) said today that it has purchased for cancellation 360,000 ordinary shares.These shares were purchased on Thursday at a price of GBP26.38 per share.Upon ...
Analogic to demonstrate BK Medical branded ultrasound systems featuring Quantum Technology
18 May 2012 - Medical imaging and aviation security technology provider Analogic Corporation (Nasdaq:ALOG) announced on Thursday that it will demonstrate the new BK Medical branded ultrasound systems, the Flex Focus 500, Flex Focus 800 and Pro Focus ...
Achillion Pharmaceuticals names EVP
18 May 2012 - Developer of small molecule drugs to combat infectious diseases Achillion Pharmaceuticals Inc (Nasdaq:ACHN), announced on Friday the promotion of Gautam Shah PhD to executive vice president.The company said that Dr Shah is also its chie...
Teva Pharmaceutical Industries re-elects chairman
18 May 2012 - Developer, producer and marketer of generic drugs and active pharmaceutical ingredients Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) announced on Friday that its board of directors has unanimously voted to re-elect Dr Phillip Frost ...
Osiris Therapeutics Inc receives world's first approval for stem cell drug Prochymal for life-threatening GvHD in children in Canada
18 May 2012 - Stem cell company Osiris Therapeutics Inc (NASDAQ:OSIR) reported on Thursday the receipt of market authorisation from Health Canada for its stem cell therapy Prochymal (remestemcel-L) for the treatment of acute graft-vs-host disease (Gv...